Opportunity ID: |
310182 |
Opportunity Number: |
NOT-EB-18-025 |
Opportunity Title: |
Notice of Intent to Issue the Funding Opportunity Announcement for Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) |
Opportunity Category: |
Discretionary |
Opportunity Category Explanation: |
|
Funding Instrument Type: |
Grant |
Category of Funding Activity: |
Health |
Category Explanation: |
|
CFDA Number(s): |
|
Eligible Applicants: |
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: |
|
Agency Code: |
HHS-NIH11 |
Agency Name: |
Department of Health and Human Services National Institutes of Health |
Posted Date: |
Nov 05, 2018 |
Last Updated Date: |
Nov 05, 2018 |
Estimated Synopsis Post Date: |
Jan 15, 2019 |
Fiscal Year: |
2019 |
Award Ceiling: |
|
Award Floor: |
|
Estimated Total Program Funding: |
|
Expected Number of Awards: |
|
Description: |
The purpose of this Notice is to inform potential applicants that the participating institutes listed above intend to issue the Bioengineering Research Grant (BRG) (R01 Clinical Trial Required) based on Funding Opportunity Announcement (FOA) at https://grants.nih.gov/grants/guide/pa-files/PAR-18-206.html. The issued BRG FOA will continue to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical or translational science. The FOA is expected to be published in January 2019 with an expected application due date in February 2019. |
Version: |
1 |